Target Health joins forces with LifeOnKey to offer clinical trials platform

26 July 2010

Target Health Inc. and LifeOnKey, Inc. have combined their products to offer a web-based information platform for the bio-pharmaceutical and medical device industries to optimize clinical trials, help researchers capture, analyze and assess trial data more efficiently, and bring innovative new medicines and devices to patients.

Through its partnership with LifeOnKey, Target Health can provide healthcare companies with an electronic clinical trial record that can manage and monitor the care of clinical trial patients from Phase I through Phase IV post-marketing surveillance.

By combining Target Health's clinical trial software with LifeOnKey's electronic health records (EHRs), the partnership will give clinicians online access to the most recent medical information for their clinical trial patients, allowing them to efficiently track critical information — from side effects to health improvements, while maintaining the integrity of the clinical trial data. Meanwhile, patients will gain the ability to follow the progress of the clinical trial through their own patient health record.

"We are very enthusiastic about building a comprehensive solution that integrates clinical trial software and EHRs — the first offering of its kind for this industry," said Target Health President Dr Jules Mitchel. "This partnership leverages the deep expertise with clinical trials and information systems within both companies to enhance the efficiency of the drug, biologic and device development process."

"This partnership clearly highlights the ultimate promise of health information technology," said Dr Linda Harnevo, CEO of LifeOnKey. "Through the smart application of information technology, we can help clinicians improve the clinical trial process from end-to-end — from better patient recruitment to more effective patient monitoring once the drug is on the market."

According to Dr. Mitchel and Dr. Harnevo, the Target Health-LifeOnKey partnership will also ensure better compliance with clinical trial requirements and help medical researchers track specific patient groups, follow product use and evaluate patient outcomes over the long term.

To top